NSCLC driven by DDR2 mutation is sensitive to dasatinib and JQ1 combination therapy

Chunxiao Xu, Kevin A. Buczkowski, Yanxi Zhang, Hajime Asahina, Ellen M. Beauchamp, Hideki Terai, Yvonne Y. Li, Matthew Meyerson, Kwok Kin Wong, Peter S. Hammerman

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)

Fingerprint

Dive into the research topics of 'NSCLC driven by DDR2 mutation is sensitive to dasatinib and JQ1 combination therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences